How Common Is Mitral Valve Stenosis and Who Gets It?

Mitral valve stenosis—a narrowing of the heart’s mitral valve that restricts blood flow—presents differently depending on geography, age, and underlying health. In high-income countries, it is relatively uncommon and most frequently develops in older adults due to calcium buildup on the valve over time ^[1]. Globally, however, rheumatic heart disease remains a major cause of mitral stenosis, particularly in areas where rheumatic fever is endemic ^[2][3].

Because researchers track broader categories like “rheumatic heart disease” or “degenerative valve disease” rather than counting isolated cases of mitral stenosis, there is no single exact number of people living with this specific valve blockage worldwide ^[4]. Ultimately, your doctor will use tests like an echocardiogram (an ultrasound of the heart)—not your age or zip code—to determine the cause and severity of your condition.

The Global Picture: Rheumatic Heart Disease

Rheumatic heart disease refers to lasting heart valve damage caused by one or more attacks of rheumatic fever. Rheumatic fever is an uncommon immune-mediated complication that can occur after certain group A streptococcal infections, such as strep throat ^[1][5]. It is important to know that not every strep infection leads to rheumatic fever, prompt treatment lowers the risk, and many people diagnosed with rheumatic valve disease do not remember ever having a severe strep infection.

The Global Burden of Disease 2021 study estimated that approximately 54.8 million people worldwide live with rheumatic heart disease ^[4]. (This number represents all rheumatic valve damage, not just mitral stenosis). This type of disease is most prominent in low- and middle-income regions, particularly in sub-Saharan Africa, South Asia, and Oceania ^[3][4]. In high-income nations, rheumatic heart disease is now less common overall but is still seen, particularly among immigrants from regions where the disease is prevalent, as well as in certain Indigenous and underserved populations ^[5][6].

Who Typically Gets It?

While anyone can develop mitral stenosis, the two most common causes follow distinct demographic patterns:

• Rheumatic Mitral Stenosis: This form typically presents in younger adults, with many patients diagnosed in their 30s, 40s, or 50s ^[7][8]. Rheumatic valve damage can remain silent for years before symptoms, pregnancy, or a routine exam lead to a diagnosis. In clinical and surgical settings, women make up a significant majority of patients treated for rheumatic mitral stenosis. This higher representation is likely due to a mix of biological factors, increased hemodynamic stress during pregnancy (which makes symptoms more noticeable), and differences in healthcare exposure ^[7][9].
• Degenerative (Calcific) Mitral Stenosis: In wealthier nations with aging populations, non-rheumatic degenerative disease is increasingly recognized ^[10][11]. This occurs as calcium deposits stiffen the valve apparatus over many years. Patients with degenerative mitral stenosis are usually older, often with an average age over 70 ^[8][12].

Note: While these are the most common pathways, rare causes of mitral stenosis include congenital (present at birth) valve abnormalities, prior radiation therapy to the chest, and certain inflammatory diseases.

Calcium Buildup vs. True Obstruction

When discussing age-related mitral valve issues, doctors frequently mention mitral annular calcification (MAC). MAC is a very common condition where calcium builds up on the ring (annulus) that supports the mitral valve ^[10].

Having MAC is not the same thing as having mitral valve stenosis. While MAC is common in older adults and is associated with chronic kidney disease and other cardiovascular conditions, only a small fraction of people with this calcification develop a hemodynamically significant obstruction—meaning a true blockage of blood flow ^[13][14][15].

Furthermore, clinically important obstruction can be present before you feel any symptoms. This is why doctors rely on Doppler echocardiography to measure blood flow and confirm if the valve is actually blocked, rather than diagnosing stenosis based on the presence of calcium alone ^[16][14].